| HOME >> BIOLOGY >> TECHNOLOGY |
====== ======
ONYX PHARMACEUTICALS, INC.
CALCULATION OF NET REVENUE (EXPENSE) FROM UNCONSOLIDATED JOINT BUSINESS
(In thousands, unaudited)
Three Months Ended Mar. 31,
---------------------------
2008 2007
------- -------
Product revenue, net $151,896 $60,881
Combined cost of goods sold,
distributed, selling, general and
administrative expenses 62,703 36,450
Combined research and development expenses 37,478 33,290
------- -------
Combined collaboration profit (loss) $51,715 $(8,859)
======= =======
Onyx's share of collaboration profit (loss) $25,858 $(4,430)
Reimbursement of Onyx's direct
development and marketing expenses 11,880 7,455
------- -------
Onyx net revenue from unconsolidated
joint business $37,738 $3,025
------- -------
ONYX PHARMACEUTICALS, INC.
CONDENSED BALANCE SHEETS
(In thousands)
Mar. 31, Dec. 31,
2008
'/>"/>
| SOURCE Onyx Pharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved |